GAMBARAN PENGGUNAAN OBAT PADA PASIEN HEPATITIS B DI RUMAH SAKIT UMUM DAERAH KABUPATEN KARANGANYAR PERIODE TAHUN 2018

Sri, Winarni (2020) GAMBARAN PENGGUNAAN OBAT PADA PASIEN HEPATITIS B DI RUMAH SAKIT UMUM DAERAH KABUPATEN KARANGANYAR PERIODE TAHUN 2018. Diploma thesis, Sekolah Tinggi Ilmu Kesehatan Nasional.

	Text Fulltext Sri Winarni.pdf Restricted to Repository staff only Download (1MB)
	Text KTI.pdf Download (1MB)

Abstract

Hepatitis B is a dangerous infectious disease. Drug selection for patients is very influential for healing hepatitis B patients. Selection of the right drug can predict the success of treatment because it can help follow-up treatment. Sampling in this study uses a saturated sampling technique. This study aims to determine the description of the use of drugs in the treatment of hepatitis B patients in the Karanganyar District General Hospital. The study is a descriptive non-analytical retrospective with the source of research data is inpatient medical records of hepatitis B patients in Karanganyar District Hospital in 2018. The time of the study was in November 2019 - December 2019. The study was conducted by calculating the percentage of characteristics of hepatitis B patients consisting of hepatitis B patients the percentage of the patient's age and the percentage of the patient's sex then calculates the treatment pattern in hepatitis B patients which includes the type of drug and the amount used. Based on the analysis it is known that hepatitis B patients the use of drugs in hepatitis B patients in Karanganyar District Hospital in the year 2018 there are 12 types of therapeutic classes, with the most use, namely the use of gastrointestinal drug classes 28.64% with the most drug use of omeprazole 10.19%; the use of the hepatoprotector drug class 24.27% with the most drug use curbuma 9.71%; use of supportive fluid group 8.74% with the most use of drug Ringer lactate 7.77%; 8.73% diuretic use with the most drug use is 4.85% furosemide; analgesic use 8.25% with the most use of drugs santagesik (metamizole) 4.35%.

Actions (login required)

View Item